Project CARE: Hereditary cancer risk checks in primary care
Official title: Project CARE: CAncer Risk Evaluation (CARE)
Run by Rutgers, The State University of New Jersey · NCT07130487 · Data updated 2026-11-12
This project will test whether sending primary care patients a chatbot link can identify people at high hereditary cancer risk and connect them to genetic counseling and testing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | November 19, 2025 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT07130487 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 18–70 who received care in Rutgers family or general internal medicine within the past two years, have internet access and contact info in EPIC/MyChart, and no prior germline cancer testing or personal cancer history.
✕Probably not a fit
Patients with a personal history of cancer, prior germline genetic testing, dementia, no internet access, or who are not English speakers are unlikely to benefit from this outreach model.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Rutgers Health will use EPIC to identify adult patients seen in family medicine or general internal medicine and invite them by email or text to consent and use a Relational Agent (chatbot) through the patient portal for cancer risk questions and genetic education. The chatbot collects family and personal history to flag patients at high hereditary cancer risk, and those flagged will be offered genetic counseling and testing. The study will measure how many patients complete the chatbot, how many are identified as high risk, and uptake of genetic services, plus feasibility and patient acceptance of the proactive digital outreach. Recruitment is limited to English-speaking patients aged 18–70 with internet access who receive care at Rutgers primary care sites and have not had prior germline cancer testing or a personal cancer history.
Why it matters
Potential benefit: If successful, this approach could increase identification of people with hereditary cancer risk in primary care and streamline timely access to genetic counseling and testing.
How similar studies have gone: Digital risk tools and chatbot-based genetic education have shown promise in improving knowledge and uptake, but proactive, study-initiated outreach for hereditary cancer risk in primary care remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Age 18 to 70 years 2. Able to read and speak English 3. Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart 4. Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years 5. Have not opted out of receiving research-related communications 6. Have internet access (via smartphone, tablet, or computer) Exclusion Criteria 1. Dementia (e.g., Alzheimer's disease) as indicated in EPIC 2. Unable to access the Internet (via smartphone, tablet, or computer) 3. Previous germline genetic testing for hereditary cancer risk 4. Opted out of research participation in EPIC 5. Have a personal history of cancer
Where it's running
-
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Anita Y Kinney, PhD, RN — Rutgers, The State University of New Jersey
- Study coordinator: Julie Chapman-Greene, PhD, MPH
- Email: chapmaje@cinj.rutgers.edu
- Phone: 732-865-3375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suicide prevention in primary care clinics in Nepal
This project will try a package of tools and training to help primary care providers in Bagmati Province, Nepal, better find and manage patients at risk of suicide.
-
Explicit 15-minute arrival-time messages to help patients arrive on time
This project will test whether showing an explicit arrival time (15 minutes before the scheduled appointment) in MyChart and automated texts helps primary care patients arrive on time for in-person visits.
-
Patient-centered clinical decision support for recommended screenings in primary care
This project will test a patient-centered computer tool that helps adults aged 18–74 and their primary care doctors identify which preventive screenings are recommended and support shared decision-making.
-
Reducing unnecessary antibiotics for urinary tract infections by improving urine collection
This study will test whether a bilingual (English and Spanish) animated video and pictorial flyer can help adults in safety‑net primary care give cleaner urine samples to reduce contaminated cultures and unnecessary antibiotic prescriptions.
-
Making AI triage more accurate for patients contacting their GP
This project will test whether updated AI in the Patchs online consultation system can make triage decisions more accurate and fair for patients contacting GP practices in England.
-
Clinic-based program to prevent teen dating violence for adolescents and caregivers
This pilot will try a clinic-delivered program that helps teens (ages 12–16) and their caregivers improve communication and reduce dating violence during routine pediatric well visits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.